Login / Signup

Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.

Qiaofeng ZhongHaizhu ChenDaoguang ChenYan QinXiaohui HeYu YangJianliang YangPeng LiuShengyu ZhouSheng YangYu ZhouLe TangChuanben ChenYuan-Kai Shi
Published in: Annals of hematology (2023)
In conclusion, we have successfully developed and validated a novel risk stratification model and a web-based survival rate calculator that demonstrated superior discriminative and predictive accuracy compared to IPI, R-IPI, and NCCN-IPI in the rituximab era.
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • free survival
  • hodgkin lymphoma
  • chronic lymphocytic leukemia